Pharma Reviews: A slowdown in private equity space will trigger more reasonable pricing in market

The historical benchmark is that when there is activity in the IPO market, ... certainly we have seen it happen sectorally in India in the pharma industry.
Read more: A slowdown in private equity space will trigger more reasonable pricing in market